Adaptation of targeted nanocarriers to changing requirements in antimalarial drug delivery

The adaptation of existing antimalarial nanocarriers to new Plasmodium stages, drugs, targeting molecules, or encapsulating structures is a strategy that can provide new nanotechnology-based, cost-efficient therapies against malaria. We have explored the modification of different liposome prototypes...

Full description

Bibliographic Details
Main Author: Marques, Joana (author)
Other Authors: Valle-Delgado, Juan José (author), Urbán, Patricia (author), Baró, Elisabet (author), Prohens, Rafel (author), Mayor, Alfredo (author), Cisteró, Pau (author), Delves, Michael (author), Sinden, Robert E. (author), Grandfils, Christian (author), de Paz, José L. (author), García-Salcedo, José A. (author), Fernàndez-Busquets, Xavier (author)
Format: article
Language:eng
Published: 2018
Subjects:
Glycosaminoglycans
Malaria
Nanomedicine
Plasmodium
Targeted drug delivery
Bioengineering
Medicine (miscellaneous)
Molecular Medicine
Biomedical Engineering
Materials Science(all)
Pharmaceutical Science
SDG 3 - Good Health and Well-being
Online Access:https://doi.org/10.1016/j.nano.2016.09.010
Country:Portugal
Oai:oai:run.unl.pt:10362/37824

Internet

https://doi.org/10.1016/j.nano.2016.09.010

Similar Items